anaxirone has been researched along with triazoles in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (90.91) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becher, R; Beelen, DW; Ehrlich, R; Grosse-Wilde, H; Quabeck, K; Schaefer, UW; Schilcher, RB; Schmidt, U; Szy, D | 1 |
| Berger, MR; Friedl, P; Rozycki-Gerlach, W; Schlag, P; Schmähl, D | 1 |
| Berger, MR; Friedl, P; Rozycki-Gerlach, W; Schlag, P; Schmähl, D; Yi, J | 1 |
| Hansen, F; Hansen, HH; Hansen, M; Lund, B | 1 |
| Banham, SW; Cunningham, D; Soukop, M | 1 |
| Abele, R; Cavalli, F; Clavel, M; Dodion, P; Gundersen, S; Renard, G; van Glabbeke, M | 1 |
| Fiebig, HH; Heim, ME; Peukert, M; Possinger, K; Queisser, W; Wander, HE | 1 |
| Arnold, H; Fiebig, HH; Henss, H; Klee, M; Peukert, M; Queisser, W; von Bültzingslöwen, F | 1 |
| Carnino, F; Dodion, P; George, M; Rotmensz, N; Scotto, V; ten Bokkel Huinink, WW; Vermorken, JB | 1 |
| Bieser, W; Fiebig, HH; Henss, H; Lohr, GW; Schmid, JR | 1 |
| Benshahar, D; Capellaere, P; Kerbrat, P; Rouëssé, JG; Thomas, D; van Coninge, CJ; van Oosterom, AT | 1 |
| Crespeigne, N; Decoster, G; Dodion, P; Gerard, B; Kenis, Y; Lambert, M; Nicaise, C; Rozencweig, M | 1 |
| Hoffmann, B; Nowrousian, MR; Schilcher, RB; Schmidt, CG; Young, JD | 1 |
| Bruntsch, U; Dodion, P; Hansen, HH; Hansen, M; Pinedo, HM; Renard, J; Ten Bokkel Huinink, WW; Van Glabbeke, M | 1 |
| Berdel, WE; Bremer, K; Peukert, M; Queisser, W; Wander, HE | 1 |
| Bremer, K; Donhujsen-Ant, R; Peukert, M; Possinger, K; Queisser, W; Wagner, H | 1 |
| Cunningham, D; Forrest, GJ; Gilchrist, NL; Kaye, SB; Setanoians, A; Soukop, M; Stuart, JF | 1 |
| Eichmann, T; Krempien, B; Manegold, C; Wingen, F | 1 |
| Bach, F; Cavalli, F; Hansen, HH; Hansen, SW; Kaplan, S | 1 |
| Hilgard, P; Peukert, M; Pohl, J | 1 |
| Billiaert, P; Blackie, RG; Calman, KC; Halbert, G; Setanoians, A; Stuart, JF; Welsh, J | 1 |
| Clavel, M; Decoster, G; Holdener, EE; Klepp, O; Ludwig, C; Pinedo, HM; Renard, G; Sessa, C; Siegenthaler, P; ten Bokkel Huinink, W | 1 |
1 trial(s) available for anaxirone and triazoles
| Article | Year |
|---|---|
Phase II trial of anaxirone (TGU) in advanced colorectal cancer: an EORTC Early Clinical Trials Group (ECTG) study.
Topics: Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Thrombocytopenia; Treatment Outcome; Triazoles | 1994 |
21 other study(ies) available for anaxirone and triazoles
| Article | Year |
|---|---|
High-dose 1,2,4-triglycidylurazol given in regimens preparatory to bone marrow transplantation. A preclinical pharmacology study.
Topics: Animals; Antineoplastic Agents; Bone Marrow Transplantation; Busulfan; Dogs; Drug Evaluation, Preclinical; Gastrointestinal Diseases; Hematologic Diseases; Triazoles; Whole-Body Irradiation | 1991 |
Anticancer drugs: studies on experimental liver infusion and additional systemic detoxification.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Female; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms, Experimental; Rats; Sarcosine; Thiocarbamates; Triazoles | 1987 |
First experiments with locoregional chemotherapy in the treatment of autochthonous rat hepatoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diethylnitrosamine; Female; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms, Experimental; Mitomycin; Mitomycins; Rats; Rats, Inbred Strains; Sarcosine; Thiocarbamates; Triazoles | 1988 |
Phase II study of 1,2,4-triglycidylurazol (TGU) in previously untreated and treated patients with small cell lung cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Small Cell; Drug Evaluation; Humans; Lung Neoplasms; Middle Aged; Prognosis; Triazoles | 1987 |
Small cell lung cancer: results of a phase II study of 1,2,4 triglycidylurazol.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Drug Evaluation; Humans; Leukocyte Count; Lung Neoplasms; Nausea; Platelet Count; Triazoles | 1986 |
Phase II trial of triglycidylurazol (TGU) in advanced malignant melanoma.
Topics: Aged; Drug Evaluation; Humans; Melanoma; Triazoles | 1987 |
Phase-II studies of 1,2,4-triglycidylurazol (TGU) in solid tumors. Phase-II Study Group of the Association of Medical Oncology of the German Cancer Society.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Prognosis; Triazoles | 1986 |
Phase II trial of anaxirone in advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Triazoles | 1987 |
Phase II trial of anaxirone (1,2,4-triglycidylurazol, TGU) in patients with advanced ovarian carcinoma: an EORTC Gynecological Cancer Cooperative Group Study.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Middle Aged; Ovarian Neoplasms; Triazoles | 1987 |
Colony assay with human tumor xenografts, murine tumors and human bone marrow. Potential for anticancer drug development.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Cell Division; Cell Survival; Cells, Cultured; Colony-Forming Units Assay; Dose-Response Relationship, Drug; In Vitro Techniques; Mice; Mice, Nude; Neoplasms, Experimental; Ribavirin; Transplantation, Heterologous; Triazoles | 1987 |
Phase II study of 1,2,4-triglycidyl urasol (TGU) in advanced soft tissue sarcoma. A trial of the EORTC Soft Tissue and Bone Sarcoma Cooperative Group.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Thrombocytopenia; Triazoles | 1987 |
Phase I study of triglycidylurazol given on a 5-day i.v. schedule.
Topics: Adult; Aged; Anemia; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Humans; Injections, Intravenous; Leukopenia; Male; Middle Aged; Neoplasms; Thrombocytopenia; Triazoles | 1986 |
Reversed-phase high-performance liquid chromatographic determination of anaxirone in biological specimens.
Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Drug Stability; Female; Half-Life; Humans; Mice; Mice, Inbred Strains; Tissue Distribution; Triazoles | 1986 |
Primary resistance of renal adenocarcinoma to 1,2,4-triglycidylurazol (TGU, NSC 332488), a new triexpoxide cytostatic agent--a phase II study of the EORTC early clinical trials group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Kidney Neoplasms; Leukopenia; Male; Middle Aged; Thrombocytopenia; Triazoles | 1986 |
1,2,4-Triglycidylurazol in advanced breast cancer: a trial of the phase II study group of the Association of Medical Oncology, German Cancer Society.
Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Female; Hematologic Diseases; Humans; Middle Aged; Triazoles | 1987 |
Phase II trial of 1,2,4-triglycidylurazol in patients with metastasized renal cell carcinoma.
Topics: Adult; Aged; Carcinoma, Renal Cell; Drug Evaluation; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Triazoles | 1987 |
A clinical and pharmacokinetic phase I study of 1,2,4-triglycidylurazol (TGU, NSC 332488).
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Kinetics; Male; Middle Aged; Neoplasms; Triazoles | 1986 |
Effects of new bisphosphonic acids on tumor-induced bone destruction in the rat.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Carcinoma 256, Walker; Diphosphonates; Male; Organophosphonates; Organophosphorus Compounds; Pamidronate; Rats; Time Factors; Triazoles | 1986 |
Phase I trial of 1,2,4-triglycidylurazol (TGU, NSC 332488): a new triepoxide cytostatic agent.
Topics: Adult; Aged; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Phlebitis; Thrombocytopenia; Triazoles | 1985 |
alpha-/beta-Triglycidyl-urazol (TGU, NSC 332488, I.N.N.: ANAXIRONE): a new chemotherapeutic agent.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Kinetics; Metabolic Clearance Rate; Mice; Neoplasms; Neoplasms, Experimental; Rats; Triazines; Triazoles | 1984 |
The analysis and animal pharmacokinetics of 1,2,4, triglycidyl urazol using a high-pressure liquid chromatographic technique.
Topics: Animals; Chromatography, High Pressure Liquid; Female; Half-Life; Mice; Triazines; Triazoles | 1984 |